世界のインスリンAPI市場予測 2020年-2025年

【英語タイトル】Global Insulin API Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP5288)・商品コード:LPI20AP5288
・発行会社(調査会社):LP Information
・発行日:2020年3月27日(※2024年版があります。お問い合わせください)
・ページ数:159
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「インスリンAPIの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、通常型ヒトインスリン、インスリンアナログなど、用途別には、速効型、プレミックス、長時間型などに区分してまとめた調査レポートです。インスリンAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・インスリンAPIの世界市場概要(サマリー)
・インスリンAPIの企業別販売量・売上
・インスリンAPIの企業別市場シェア
・インスリンAPIの世界市場規模 2015年-2020年:種類別(通常型ヒトインスリン、インスリンアナログ)
・インスリンAPIの世界市場規模 2015年-2020年:用途別(速効型、プレミックス、長時間型)
・インスリンAPIの米州市場規模(アメリカ、カナダ、メキシコなど)
・インスリンAPIのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・インスリンAPIの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インスリンAPIの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・インスリンAPI市場の成長要因・課題・動向
・インスリンAPIの世界市場予測 2021年-2025年
・インスリンAPIの米州市場予測(アメリカ、カナダ、メキシコなど)
・インスリンAPIのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・インスリンAPIの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インスリンAPIの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・インスリンAPIの世界市場予測:種類別(通常型ヒトインスリン、インスリンアナログ)
・インスリンAPIの世界市場予測:用途別(速効型、プレミックス、長時間型)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Insulin API market will register a 4.5% CAGR in terms of revenue, the global market size will reach $ 2110.8 million by 2025, from $ 1772.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin API business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin API market by type, application, key manufacturers and key regions and countries.

This study considers the Insulin API value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Regular Human Insulin
Insulin Analogue

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Fast-acting
Premix
Long-acting

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Julphar Diabetes
Sanofi-Aventis
Tonghua Dongbao
United Laboratory
Eli Lilly
Amphastar
Biocon
Ganlee
Torrent Pharma
Wockhardt

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Insulin API consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Insulin API market by identifying its various subsegments.
Focuses on the key global Insulin API manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin API with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin API submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin API Consumption 2015-2025
2.1.2 Insulin API Consumption CAGR by Region
2.2 Insulin API Segment by Type
2.2.1 Regular Human Insulin
2.2.2 Insulin Analogue
2.3 Insulin API Consumption by Type
2.3.1 Global Insulin API Consumption Market Share by Type (2015-2020)
2.3.2 Global Insulin API Revenue and Market Share by Type (2015-2020)
2.3.3 Global Insulin API Sale Price by Type (2015-2020)
2.4 Insulin API Segment by Application
2.4.1 Fast-acting
2.4.2 Premix
2.4.3 Long-acting
2.5 Insulin API Consumption by Application
2.5.1 Global Insulin API Consumption Market Share by Type (2015-2020)
2.5.2 Global Insulin API Value and Market Share by Type (2015-2020)
2.5.3 Global Insulin API Sale Price by Type (2015-2020)

3 Global Insulin API by Company
3.1 Global Insulin API Sales Market Share by Company
3.1.1 Global Insulin API Sales by Company (2018-2020)
3.1.2 Global Insulin API Sales Market Share by Company (2018-2020)
3.2 Global Insulin API Revenue Market Share by Company
3.2.1 Global Insulin API Revenue by Company (2018-2020)
3.2.2 Global Insulin API Revenue Market Share by Company (2018-2020)
3.3 Global Insulin API Sale Price by Company
3.4 Global Insulin API Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Insulin API Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Insulin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Insulin API by Regions
4.1 Insulin API by Regions
4.2 Americas Insulin API Consumption Growth
4.3 APAC Insulin API Consumption Growth
4.4 Europe Insulin API Consumption Growth
4.5 Middle East & Africa Insulin API Consumption Growth

5 Americas
5.1 Americas Insulin API Consumption by Countries
5.1.1 Americas Insulin API Consumption by Countries (2015-2020)
5.1.2 Americas Insulin API Value by Countries (2015-2020)
5.2 Americas Insulin API Consumption by Type
5.3 Americas Insulin API Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Insulin API Consumption by Regions
6.1.1 APAC Insulin API Consumption by Regions (2015-2020)
6.1.2 APAC Insulin API Value by Regions (2015-2020)
6.2 APAC Insulin API Consumption by Type
6.3 APAC Insulin API Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Insulin API by Countries
7.1.1 Europe Insulin API Consumption by Countries (2015-2020)
7.1.2 Europe Insulin API Value by Countries (2015-2020)
7.2 Europe Insulin API Consumption by Type
7.3 Europe Insulin API Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Insulin API by Countries
8.1.1 Middle East & Africa Insulin API Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Insulin API Value by Countries (2015-2020)
8.2 Middle East & Africa Insulin API Consumption by Type
8.3 Middle East & Africa Insulin API Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Insulin API Distributors
10.3 Insulin API Customer

11 Global Insulin API Market Forecast
11.1 Global Insulin API Consumption Forecast (2021-2025)
11.2 Global Insulin API Forecast by Regions
11.2.1 Global Insulin API Forecast by Regions (2021-2025)
11.2.2 Global Insulin API Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Insulin API Forecast by Type
11.8 Global Insulin API Forecast by Application

12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Information
12.1.2 Insulin API Product Offered
12.1.3 Novo Nordisk Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk Latest Developments
12.2 Julphar Diabetes
12.2.1 Company Information
12.2.2 Insulin API Product Offered
12.2.3 Julphar Diabetes Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Julphar Diabetes Latest Developments
12.3 Sanofi-Aventis
12.3.1 Company Information
12.3.2 Insulin API Product Offered
12.3.3 Sanofi-Aventis Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi-Aventis Latest Developments
12.4 Tonghua Dongbao
12.4.1 Company Information
12.4.2 Insulin API Product Offered
12.4.3 Tonghua Dongbao Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Tonghua Dongbao Latest Developments
12.5 United Laboratory
12.5.1 Company Information
12.5.2 Insulin API Product Offered
12.5.3 United Laboratory Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 United Laboratory Latest Developments
12.6 Eli Lilly
12.6.1 Company Information
12.6.2 Insulin API Product Offered
12.6.3 Eli Lilly Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Eli Lilly Latest Developments
12.7 Amphastar
12.7.1 Company Information
12.7.2 Insulin API Product Offered
12.7.3 Amphastar Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Amphastar Latest Developments
12.8 Biocon
12.8.1 Company Information
12.8.2 Insulin API Product Offered
12.8.3 Biocon Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Biocon Latest Developments
12.9 Ganlee
12.9.1 Company Information
12.9.2 Insulin API Product Offered
12.9.3 Ganlee Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Ganlee Latest Developments
12.10 Torrent Pharma
12.10.1 Company Information
12.10.2 Insulin API Product Offered
12.10.3 Torrent Pharma Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Torrent Pharma Latest Developments
12.11 Wockhardt
12.11.1 Company Information
12.11.2 Insulin API Product Offered
12.11.3 Wockhardt Insulin API Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Wockhardt Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Insulin API Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Regular Human Insulin
Table 5. Major Players of Insulin Analogue
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Insulin API Consumption Market Share by Type (2015-2020)
Table 8. Global Insulin API Revenue by Type (2015-2020) ($ million)
Table 9. Global Insulin API Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Insulin API Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Insulin API Consumption Market Share by Application (2015-2020)
Table 13. Global Insulin API Value by Application (2015-2020)
Table 14. Global Insulin API Value Market Share by Application (2015-2020)
Table 15. Global Insulin API Sale Price by Application (2015-2020)
Table 16. Global Insulin API Sales by Company (2017-2019) (Kg)
Table 17. Global Insulin API Sales Market Share by Company (2017-2019)
Table 18. Global Insulin API Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Insulin API Revenue Market Share by Company (2017-2019)
Table 20. Global Insulin API Sale Price by Company (2017-2019)
Table 21. Global Insulin API Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Insulin API Products Offered
Table 23. Insulin API Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Insulin API Consumption by Regions 2015-2020 (Kg)
Table 25. Global Insulin API Consumption Market Share by Regions 2015-2020
Table 26. Global Insulin API Value by Regions 2015-2020 ($ Millions)
Table 27. Global Insulin API Value Market Share by Regions 2015-2020
Table 28. Americas Insulin API Consumption by Countries (2015-2020) (Kg)
Table 29. Americas Insulin API Consumption Market Share by Countries (2015-2020)
Table 30. Americas Insulin API Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Insulin API Value Market Share by Countries (2015-2020)
Table 32. Americas Insulin API Consumption by Type (2015-2020) (Kg)
Table 33. Americas Insulin API Consumption Market Share by Type (2015-2020)
Table 34. Americas Insulin API Consumption by Application (2015-2020) (Kg)
Table 35. Americas Insulin API Consumption Market Share by Application (2015-2020)
Table 36. APAC Insulin API Consumption by Countries (2015-2020) (Kg)
Table 37. APAC Insulin API Consumption Market Share by Countries (2015-2020)
Table 38. APAC Insulin API Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Insulin API Value Market Share by Regions (2015-2020)
Table 40. APAC Insulin API Consumption by Type (2015-2020) (Kg)
Table 41. APAC Insulin API Consumption Market Share by Type (2015-2020)
Table 42. APAC Insulin API Consumption by Application (2015-2020) (Kg)
Table 43. APAC Insulin API Consumption Market Share by Application (2015-2020)
Table 44. Europe Insulin API Consumption by Countries (2015-2020) (Kg)
Table 45. Europe Insulin API Consumption Market Share by Countries (2015-2020)
Table 46. Europe Insulin API Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Insulin API Value Market Share by Countries (2015-2020)
Table 48. Europe Insulin API Consumption by Type (2015-2020) (Kg)
Table 49. Europe Insulin API Consumption Market Share by Type (2015-2020)
Table 50. Europe Insulin API Consumption by Application (2015-2020) (Kg)
Table 51. Europe Insulin API Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Insulin API Consumption by Countries (2015-2020) (Kg)
Table 53. Middle East & Africa Insulin API Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Insulin API Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Insulin API Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Insulin API Consumption by Type (2015-2020) (Kg)
Table 57. Middle East & Africa Insulin API Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Insulin API Consumption by Application (2015-2020) (Kg)
Table 59. Middle East & Africa Insulin API Consumption Market Share by Application (2015-2020)
Table 60. Insulin API Distributors List
Table 61. Insulin API Customer List
Table 62. Global Insulin API Consumption Forecast by Countries (2021-2025) (Kg)
Table 63. Global Insulin API Consumption Market Forecast by Regions
Table 64. Global Insulin API Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Insulin API Value Market Share Forecast by Regions
Table 66. Global Insulin API Consumption Forecast by Type (2021-2025) (Kg)
Table 67. Global Insulin API Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Insulin API Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Insulin API Value Market Share Forecast by Type (2021-2025)
Table 70. Global Insulin API Consumption Forecast by Application (2021-2025) (Kg)
Table 71. Global Insulin API Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Insulin API Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Insulin API Value Market Share Forecast by Application (2021-2025)
Table 74. Novo Nordisk Product Offered
Table 75. Novo Nordisk Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Novo Nordisk Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 79. Julphar Diabetes Product Offered
Table 80. Julphar Diabetes Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 81. Julphar Diabetes Main Business
Table 82. Julphar Diabetes Latest Developments
Table 83. Julphar Diabetes Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi-Aventis Product Offered
Table 85. Sanofi-Aventis Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 86. Sanofi-Aventis Main Business
Table 87. Sanofi-Aventis Latest Developments
Table 88. Sanofi-Aventis Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Tonghua Dongbao Product Offered
Table 90. Tonghua Dongbao Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 91. Tonghua Dongbao Main Business
Table 92. Tonghua Dongbao Latest Developments
Table 93. Tonghua Dongbao Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 94. United Laboratory Product Offered
Table 95. United Laboratory Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 96. United Laboratory Main Business
Table 97. United Laboratory Latest Developments
Table 98. United Laboratory Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly Product Offered
Table 100. Eli Lilly Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Latest Developments
Table 103. Eli Lilly Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Amphastar Product Offered
Table 105. Amphastar Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 106. Amphastar Main Business
Table 107. Amphastar Latest Developments
Table 108. Amphastar Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 109. Biocon Product Offered
Table 110. Biocon Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 111. Biocon Main Business
Table 112. Biocon Latest Developments
Table 113. Biocon Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Ganlee Product Offered
Table 115. Ganlee Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 116. Ganlee Main Business
Table 117. Ganlee Latest Developments
Table 118. Ganlee Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Torrent Pharma Product Offered
Table 120. Torrent Pharma Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 121. Torrent Pharma Main Business
Table 122. Torrent Pharma Latest Developments
Table 123. Torrent Pharma Basic Information, Company Total Revenue (in $ million), Insulin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Wockhardt Product Offered
Table 125. Wockhardt Insulin API Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2020E)
Table 126. Wockhardt Main Business
Table 127. Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Wockhardt Latest Developments
List of Figures
Figure 1. Picture of Insulin API
Figure 2. Insulin API Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Insulin API Consumption Growth Rate 2015-2025 (Kg)
Figure 5. Global Insulin API Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Regular Human Insulin
Figure 7. Product Picture of Insulin Analogue
Figure 8. Global Insulin API Consumption Market Share by Type (2015-2020)
Figure 9. Global Insulin API Value Market Share by Type (2015-2020)
Figure 10. Insulin API Consumed in Fast-acting
Figure 11. Global Insulin API Market: Fast-acting (2015-2020) (Kg)
Figure 12. Global Insulin API Market: Fast-acting (2015-2020) ($ Millions)
Figure 13. Insulin API Consumed in Premix
Figure 14. Global Insulin API Market: Premix (2015-2020) (Kg)
Figure 15. Global Insulin API Market: Premix (2015-2020) ($ Millions)
Figure 16. Insulin API Consumed in Long-acting
Figure 17. Global Insulin API Market: Long-acting (2015-2020) (Kg)
Figure 18. Global Insulin API Market: Long-acting (2015-2020) ($ Millions)
Figure 19. Global Insulin API Consumption Market Share by Application (2015-2020)
Figure 20. Global Insulin API Value Market Share by Application (2015-2020)
Figure 21. Global Insulin API Sales Market Share by Company in 2017
Figure 22. Global Insulin API Sales Market Share by Company in 2019
Figure 23. Global Insulin API Revenue Market Share by Company in 2017
Figure 24. Global Insulin API Revenue Market Share by Company in 2019
Figure 25. Global Insulin API Sale Price by Company in 2019
Figure 26. Global Insulin API Consumption Market Share by Regions 2015-2020
Figure 27. Global Insulin API Value Market Share by Regions 2015-2020
Figure 28. Americas Insulin API Consumption 2015-2020 (Kg)
Figure 29. Americas Insulin API Value 2015-2020 ($ Millions)
Figure 30. APAC Insulin API Consumption 2015-2020 (Kg)
Figure 31. APAC Insulin API Value 2015-2020 ($ Millions)
Figure 32. Europe Insulin API Consumption 2015-2020 (Kg)
Figure 33. Europe Insulin API Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Insulin API Consumption 2015-2020 (Kg)
Figure 35. Middle East & Africa Insulin API Value 2015-2020 ($ Millions)
Figure 36. Americas Insulin API Consumption Market Share by Countries in 2019
Figure 37. Americas Insulin API Value Market Share by Countries in 2019
Figure 38. Americas Insulin API Consumption Market Share by Type in 2019
Figure 39. Americas Insulin API Consumption Market Share by Application in 2019
Figure 40. United States Insulin API Consumption Growth 2015-2020 (Kg)
Figure 41. United States Insulin API Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Insulin API Consumption Growth 2015-2020 (Kg)
Figure 43. Canada Insulin API Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Insulin API Consumption Growth 2015-2020 (Kg)
Figure 45. Mexico Insulin API Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Insulin API Consumption Market Share by Countries in 2019
Figure 47. APAC Insulin API Value Market Share by Regions in 2019
Figure 48. APAC Insulin API Consumption Market Share by Type in 2019
Figure 49. APAC Insulin API Consumption Market Share by Application in 2019
Figure 50. China Insulin API Consumption Growth 2015-2020 (Kg)
Figure 51. China Insulin API Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Insulin API Consumption Growth 2015-2020 (Kg)
Figure 53. Japan Insulin API Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Insulin API Consumption Growth 2015-2020 (Kg)
Figure 55. Korea Insulin API Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Insulin API Consumption Growth 2015-2020 (Kg)
Figure 57. Southeast Asia Insulin API Value Growth 2015-2020 ($ Millions)
Figure 58. India Insulin API Consumption Growth 2015-2020 (Kg)
Figure 59. India Insulin API Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Insulin API Consumption Growth 2015-2020 (Kg)
Figure 61. Australia Insulin API Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Insulin API Consumption Market Share by Countries in 2019
Figure 63. Europe Insulin API Value Market Share by Countries in 2019
Figure 64. Europe Insulin API Consumption Market Share by Type in 2019
Figure 65. Europe Insulin API Consumption Market Share by Application in 2019
Figure 66. Germany Insulin API Consumption Growth 2015-2020 (Kg)
Figure 67. Germany Insulin API Value Growth 2015-2020 ($ Millions)
Figure 68. France Insulin API Consumption Growth 2015-2020 (Kg)
Figure 69. France Insulin API Value Growth 2015-2020 ($ Millions)
Figure 70. UK Insulin API Consumption Growth 2015-2020 (Kg)
Figure 71. UK Insulin API Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Insulin API Consumption Growth 2015-2020 (Kg)
Figure 73. Italy Insulin API Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Insulin API Consumption Growth 2015-2020 (Kg)
Figure 75. Russia Insulin API Value Growth 2015-2020 ($ Millions)
Figure 76. Spain Insulin API Consumption Growth 2015-2020 (Kg)
Figure 77. Spain Insulin API Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Insulin API Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Insulin API Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Insulin API Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Insulin API Consumption Market Share by Application in 2019
Figure 82. Egypt Insulin API Consumption Growth 2015-2020 (Kg)
Figure 83. Egypt Insulin API Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Insulin API Consumption Growth 2015-2020 (Kg)
Figure 85. South Africa Insulin API Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Insulin API Consumption Growth 2015-2020 (Kg)
Figure 87. Israel Insulin API Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Insulin API Consumption Growth 2015-2020 (Kg)
Figure 89. Turkey Insulin API Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Insulin API Consumption Growth 2015-2020 (Kg)
Figure 91. GCC Countries Insulin API Value Growth 2015-2020 ($ Millions)
Figure 92. Global Insulin API Consumption Growth Rate Forecast (2021-2025) (Kg)
Figure 93. Global Insulin API Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Insulin API Consumption 2021-2025 (Kg)
Figure 95. Americas Insulin API Value 2021-2025 ($ Millions)
Figure 96. APAC Insulin API Consumption 2021-2025 (Kg)
Figure 97. APAC Insulin API Value 2021-2025 ($ Millions)
Figure 98. Europe Insulin API Consumption 2021-2025 (Kg)
Figure 99. Europe Insulin API Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Insulin API Consumption 2021-2025 (Kg)
Figure 101. Middle East & Africa Insulin API Value 2021-2025 ($ Millions)
Figure 102. United States Insulin API Consumption 2021-2025 (Kg)
Figure 103. United States Insulin API Value 2021-2025 ($ Millions)
Figure 104. Canada Insulin API Consumption 2021-2025 (Kg)
Figure 105. Canada Insulin API Value 2021-2025 ($ Millions)
Figure 106. Mexico Insulin API Consumption 2021-2025 (Kg)
Figure 107. Mexico Insulin API Value 2021-2025 ($ Millions)
Figure 108. Brazil Insulin API Consumption 2021-2025 (Kg)
Figure 109. Brazil Insulin API Value 2021-2025 ($ Millions)
Figure 110. China Insulin API Consumption 2021-2025 (Kg)
Figure 111. China Insulin API Value 2021-2025 ($ Millions)
Figure 112. Japan Insulin API Consumption 2021-2025 (Kg)
Figure 113. Japan Insulin API Value 2021-2025 ($ Millions)
Figure 114. Korea Insulin API Consumption 2021-2025 (Kg)
Figure 115. Korea Insulin API Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Insulin API Consumption 2021-2025 (Kg)
Figure 117. Southeast Asia Insulin API Value 2021-2025 ($ Millions)
Figure 118. India Insulin API Consumption 2021-2025 (Kg)
Figure 119. India Insulin API Value 2021-2025 ($ Millions)
Figure 120. Australia Insulin API Consumption 2021-2025 (Kg)
Figure 121. Australia Insulin API Value 2021-2025 ($ Millions)
Figure 122. Germany Insulin API Consumption 2021-2025 (Kg)
Figure 123. Germany Insulin API Value 2021-2025 ($ Millions)
Figure 124. France Insulin API Consumption 2021-2025 (Kg)
Figure 125. France Insulin API Value 2021-2025 ($ Millions)
Figure 126. UK Insulin API Consumption 2021-2025 (Kg)
Figure 127. UK Insulin API Value 2021-2025 ($ Millions)
Figure 128. Italy Insulin API Consumption 2021-2025 (Kg)
Figure 129. Italy Insulin API Value 2021-2025 ($ Millions)
Figure 130. Russia Insulin API Consumption 2021-2025 (Kg)
Figure 131. Russia Insulin API Value 2021-2025 ($ Millions)
Figure 132. Spain Insulin API Consumption 2021-2025 (Kg)
Figure 133. Spain Insulin API Value 2021-2025 ($ Millions)
Figure 134. Egypt Insulin API Consumption 2021-2025 (Kg)
Figure 135. Egypt Insulin API Value 2021-2025 ($ Millions)
Figure 136. South Africa Insulin API Consumption 2021-2025 (Kg)
Figure 137. South Africa Insulin API Value 2021-2025 ($ Millions)
Figure 138. Israel Insulin API Consumption 2021-2025 (Kg)
Figure 139. Israel Insulin API Value 2021-2025 ($ Millions)
Figure 140. Turkey Insulin API Consumption 2021-2025 (Kg)
Figure 141. Turkey Insulin API Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Insulin API Consumption 2021-2025 (Kg)
Figure 143. GCC Countries Insulin API Value 2021-2025 ($ Millions)
Figure 144. Novo Nordisk Insulin API Market Share (2018-2020)
Figure 145. Julphar Diabetes Insulin API Market Share (2018-2020)
Figure 146. Sanofi-Aventis Insulin API Market Share (2018-2020)
Figure 147. Tonghua Dongbao Insulin API Market Share (2018-2020)
Figure 148. United Laboratory Insulin API Market Share (2018-2020)
Figure 149. Eli Lilly Insulin API Market Share (2018-2020)
Figure 150. Amphastar Insulin API Market Share (2018-2020)
Figure 151. Biocon Insulin API Market Share (2018-2020)
Figure 152. Ganlee Insulin API Market Share (2018-2020)
Figure 153. Torrent Pharma Insulin API Market Share (2018-2020)
Figure 154. Wockhardt Insulin API Market Share (2018-2020)


★調査レポート[世界のインスリンAPI市場予測 2020年-2025年] (コード:LPI20AP5288)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインスリンAPI市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆